Physician | Molecular Genomic Pathologist | Duarte, CA - Full-time

Physician | Molecular Genomic Pathologist | Duarte, CA - (10035860)

Description

City of Hope Medical Group Seeks a Molecular Genomic Pathologist to join our Growing Team.

Join one of the top cancer centers in the nation! Our rapidly expanding, nationally recognized cancer institute seeks to hire a full-time academic Molecular Genomic Pathologist at the Assistant/Associate level within Department of Pathology to join City of Hope in Duarte, CA. We are seeking academic-oriented and mission- minded physicians, as every discovery we make and every new treatment we create gives people the chance to live longer, better, and more fully.

Position Highlights:

The successful candidate will serve as a faculty clinician in the Division of Molecular Pathology and Therapy Biomarkers, with primary clinical, educational, and scholarly responsibilities in the Clinical Molecular Diagnostics Laboratory (CMDL), a core diagnostic laboratory within the City of Hope Clinical Molecular Genomics and Cytogenomics (CMGCL) CLIA Laboratory. The faculty member will work collaboratively with a diverse and nationally recognized team of physicians, pathologists, scientists, and laboratory professionals to advance excellence in genomic diagnostics, translational research, education, and patient-centered care.

The Clinical Molecular Diagnostics Laboratory, located at Rivergrade within the Molecular Pathology, Genomics, and Cytogenomics CLIA Laboratory, is a high-volume, state-of-the-art program performing more than 39,000 moderate to high complexity molecular tests annually across solid tumors and hematologic malignancies.
*Inquire For More Details!

Qualifications:

Minimum Education / Work Experience

• Medical Doctor (MD) or Doctor of Osteopathic Medicine (DO) degree.
• Board eligible or board certified in Molecular Genetic Pathology (MGP) or Molecular Genomic Pathology.
• Board certified in Anatomic Pathology and/or Clinical Pathology (AP/CP preferred) through the American Board of Pathology.
• Eligible for unrestricted medical licensure in the State of California.
• A minimum of two (2) years of experience working in or directing a clinical Molecular Genomic Pathology laboratory is preferred. Exceptionally qualified candidates with fellowship training and demonstrated academic potential will also be considered.

Preferred Qualifications

• Board certified in Molecular Genetic Pathology (MGP) by the American Board of Pathology.
• Additional fellowship training and/or board certification in Hematopathology, Cytogenetics, Clinical Informatics, or related disciplines is desirable.
• More than two (2) years of faculty experience in an academic molecular pathology program.
• Experience with translational research, Institutional Review Board (IRB) protocols, grant-supported research, and advanced molecular genomics methodologies, including whole-genome sequencing, optical genome mapping, CytoScan, OncoScan, and other genome-wide array technologies.
• Demonstrated ability to develop strategic plans for program growth, test utilization, laboratory integration, and expansion of molecular diagnostic services.
• Record of scholarly activity, including peer-reviewed publications, translational research, grant funding, or clinical trial support.
• Experience mentoring residents, fellows, graduate students, or junior faculty.

About City of Hope

City of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases. Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution.  AccessHopeTM, a wholly owned subsidiary, was launched in 2019 and is dedicated to serving employers and their health care partners by providing access to City of Hope’s exceptional cancer expertise. A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.

Recently, the organization extended its reach beyond Duarte to include clinical network sites in Los Angeles, Orange, Riverside, and San Bernardino counties, steadily moving it to number one in Southern California for inpatient market share and pushing its capacity limits. In 2018, City of Hope began a transformational journey with ambitious goals in the areas of patient care, value-based care and precision medicine, hematology malignancies, stem cell transplants, and meaningful innovations and cures. Integral to the realization of these goals is the expansion of City of Hope to the Orange County market. 

Our community includes research associates, scientists, doctors, nurses, allied health professionals, graduate students, fundraising specialists, marketing professionals, volunteers and an extensive support staff. We are united by our desire to find cures, save lives and transform the future of health. Every discovery we make and every new treatment we create gives people the chance to live longer, better and more fully.

City of Hope continues to be a pioneer of patient-centered care and remains committed to its tradition of exceptional care for patients, families and and communities. Each day, we live out our credo:

"There is no profit in curing the body, if, in the process, we destroy the soul."